These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8513656)

  • 1. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
    Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
    Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose disulfiram does not inhibit CYP2A6 activity.
    Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
    Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical enflurane metabolism by cytochrome P450 2E1.
    Kharasch ED; Thummel KE; Mautz D; Bosse S
    Clin Pharmacol Ther; 1994 Apr; 55(4):434-40. PubMed ID: 8162670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis.
    Kharasch ED; Hankins D; Mautz D; Thummel KE
    Lancet; 1996 May; 347(9012):1367-71. PubMed ID: 8637342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory toxicity of diethyldithiocarbamate (DDTC) and disulfiram and the protective effect of DDTC against the olfactory toxicity of dichlobenil.
    Deamer NJ; Genter MB
    Chem Biol Interact; 1995 Apr; 95(3):215-26. PubMed ID: 7728893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation.
    Kharasch ED; Armstrong AS; Gunn K; Artru A; Cox K; Karol MD
    Anesthesiology; 1995 Jun; 82(6):1379-88. PubMed ID: 7793652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone.
    Carriere V; Goasduff T; Ratanasavanh D; Morel F; Gautier JC; Guillouzo A; Beaune P; Berthou F
    Chem Res Toxicol; 1993; 6(6):852-7. PubMed ID: 7509644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
    Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
    Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
    Gebhardt AC; Lucas D; Ménez JF; Seitz HK
    Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
    Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF; Branch RA
    Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans.
    Emery MG; Jubert C; Thummel KE; Kharasch ED
    J Pharmacol Exp Ther; 1999 Oct; 291(1):213-9. PubMed ID: 10490907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in the disposition of chlorzoxazone.
    de Vries JD; Salphati L; Horie S; Becker CE; Hoener BA
    Biopharm Drug Dispos; 1994 Oct; 15(7):587-97. PubMed ID: 7849234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.